Expand RYTM Menu
RYTM MENU

RYTM Stock Posts


Unusual Option Volume

RYTM Rhythm Pharmaceuticals93.43+6.99 (+8.1%)

Rhythm Pharmaceuticals trades 2,195 contracts. The company has the following event: 3rd Annual Guggenheim Healthcare Innovation Conference on Nov 9, 2026. News: Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome
View Details...
RYTM #RhythmPharmaceuticals stock declines -5.0% in after hours trading. See the latest news.

After Hours Decliner

RYTM Rhythm Pharmaceuticals90.51+3.13+3.6%

After Hours:86.00-4.51 (-5.0%)

Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

Globe NewswireMon, 16-Mar 4:01 PM
RYTM #RhythmPharmaceuticals stock declines -5.0% in after hours trading. See the latest news.

After Hours Decliner

RYTM Rhythm Pharmaceuticals90.51+3.13+3.6%

After Hours:86.00-4.51 (-5.0%)

Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

Globe NewswireMon, 16-Mar 4:01 PM
RYTM #RhythmPharmaceuticals stock increases 3.8% after hours.

After Hours Gainer

RYTM Rhythm Pharmaceuticals104.77+4.06+4.0%

After Hours:108.80+4.03 (+3.9%)

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Globe NewswireWed, 10-Dec 4:01 PM
RYTM #RhythmPharmaceuticals stock increases 3.8% after hours.

After Hours Gainer

RYTM Rhythm Pharmaceuticals104.77+4.06+4.0%

After Hours:108.80+4.03 (+3.9%)

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Globe NewswireWed, 10-Dec 4:01 PM
Unusual Option Volume

RYTM Rhythm Pharmaceuticals100.79+0.10 (+0.1%)

Rhythm Pharmaceuticals trades 2,744 contracts. The company has the following event: on Mar 20, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes